Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxue Runchang is a Traditional Chinese Medicine (TCM) formulation specifically developed and modernized for the treatment of postpartum constipation. Developed by the Changsha Innovative Traditional Chinese Medicine Modernization Research Institute, the formula is based on the therapeutic principle of nourishing the blood to moisten the intestines (Yangxue Runchang). It typically comprises a synergistic blend of herbs including *Angelica sinensis* (Dang Gui), *Rehmannia glutinosa* (Di Huang), *Cannabis semen* (Huo Ma Ren), *Prunus persica* (Tao Ren), and *Citrus aurantium* (Zhi Qiao). The mechanism of action involves increasing intestinal fluid secretion and lubrication while promoting gastrointestinal peristalsis, thereby facilitating easier stool passage without the irritation associated with stimulant laxatives. This approach is particularly suited for the blood deficiency and intestinal dryness pattern frequently observed in women following childbirth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxue Runchang.